FR2279412B1 - - Google Patents

Info

Publication number
FR2279412B1
FR2279412B1 FR7426216A FR7426216A FR2279412B1 FR 2279412 B1 FR2279412 B1 FR 2279412B1 FR 7426216 A FR7426216 A FR 7426216A FR 7426216 A FR7426216 A FR 7426216A FR 2279412 B1 FR2279412 B1 FR 2279412B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7426216A
Other versions
FR2279412A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FR2279412A1 publication Critical patent/FR2279412A1/fr
Application granted granted Critical
Publication of FR2279412B1 publication Critical patent/FR2279412B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7426216A 1973-08-01 1974-07-29 Procede pour reduire les effets secondaires des aminoglucosides antibiotiques et composition pharmaceutique contenant les aminoglucosides antibiotiques resultant de ce procede Granted FR2279412A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8584673 1973-08-01

Publications (2)

Publication Number Publication Date
FR2279412A1 FR2279412A1 (fr) 1976-02-20
FR2279412B1 true FR2279412B1 (fr) 1980-02-15

Family

ID=13870221

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426216A Granted FR2279412A1 (fr) 1973-08-01 1974-07-29 Procede pour reduire les effets secondaires des aminoglucosides antibiotiques et composition pharmaceutique contenant les aminoglucosides antibiotiques resultant de ce procede

Country Status (4)

Country Link
US (1) US3962429A (fr)
DE (1) DE2437144A1 (fr)
FR (1) FR2279412A1 (fr)
GB (1) GB1470676A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52128232A (en) * 1976-04-16 1977-10-27 Meiji Seika Kaisha Ltd Drugs for alleviating toxicity to kidneys
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
CA1237670A (fr) * 1983-05-26 1988-06-07 Andrew S. Janoff Reduction de la toxicite de certains medicaments
CA1270198A (fr) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation d'agents antineoplastiques dans des liposones
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
HU197514B (en) * 1985-03-07 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of injection sulution containing acid-additional salts od sysomicin
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5079234A (en) * 1989-03-23 1992-01-07 Bristol-Myers Squibb Co. Inhibitors of aminoglycoside nephrotoxicity
DK0555229T3 (da) * 1990-07-31 1996-08-19 Liposome Co Inc Akkumulation af aminosyrer og peptider i liposomer
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
CA2615315C (fr) * 2005-07-18 2015-10-06 Basf Aktiengesellschaft Utilisation de dimethyle disulfure pour une production de methionine dans des micro-organismes
US20070105782A1 (en) * 2005-10-07 2007-05-10 Board Of Trustees Of Southern Illinois University Protectant Combinations for Reducing Toxicities
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions

Also Published As

Publication number Publication date
US3962429A (en) 1976-06-08
GB1470676A (en) 1977-04-21
FR2279412A1 (fr) 1976-02-20
DE2437144A1 (de) 1975-02-13

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
FR2279412B1 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU477823B2 (fr)
AR193950A1 (fr)
AR195311A1 (fr)
AR197627A1 (fr)
AU471461B2 (fr)
AU476873B1 (fr)
AR195948A1 (fr)
AU477824B2 (fr)
AR196382A1 (fr)
AR196123Q (fr)
AR196212Q (fr)
AU479539A (fr)
AU479404A (fr)
AU479562A (fr)
BG19338A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse